SEC Form 4 · accession 0001654954-18-005773
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gang Jacky Ji
Director
Period of report
May 18, 2018
Accepted (ET)
May 22, 2018 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) (2014 Plan)F1 | $19.71 | May 18, 2018 | A | 2,947 | A | Apr 26, 2019 | May 18, 2028 | Common Stock | 2,947 | 11,493 | D |
Explanation of responses
- F1This option becomes exercisable and fully vests on April 26, 2019.